Streetbeat News

Products Services

NVO

A Pew Research Center survey reveals skepticism among Americans regarding the effectiveness of weight loss drugs Ozempic and Wegovy, produced by Novo Nordisk (NYSE:NVO), in significantly reducing the country's obesity rate. Despite the drugs' FDA approval for managing Type 2 diabetes and long-term weight management, only 35% of respondents believe they will somewhat reduce obesity. Concerns include rising drug prices, counterfeit versions, and the need for food companies to adjust their offerings.

Portfolio Pulse from Benzinga Neuro

February 28, 2024 | 1:31 pm

ALTM

LZM

NEM

The article highlights the top 3 materials stocks that are currently oversold according to their RSI values, suggesting potential buying opportunities. Arcadium Lithium plc (ALTM) reported better-than-expected quarterly earnings, Newmont Corporation (NEM) announced a 24% Y/Y increase in fourth-quarter revenue, and Lifezone Metals Limited (LZM) revealed a development plan for the Kabanga Nickel Project. Despite positive developments, all three stocks have seen recent declines in their stock prices.

Portfolio Pulse from Avi Kapoor

February 28, 2024 | 1:31 pm

ICAD

iCAD, Inc. (NASDAQ:ICAD) showcased clinical data at ECR 2024, demonstrating the effectiveness of its AI-powered ProFound Detection in reducing breast interval cancer rates and recall rates, while also decreasing radiology reading workload. The company also introduced new features for ProFound Detection, aimed at improving mammogram readability for radiologists. Additionally, iCAD presented research on using Breast Arterial Calcification detection as a biomarker for cardiovascular disease in women. The company highlighted its expanded cloud platform and subscription licensing plans.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:27 pm

CMG

Chipotle Mexican Grill (NYSE:CMG) has announced a doubling of its commitment to the Cultivate Next venture fund, increasing its investment by $50 million to a total of $100 million. The fund, introduced in 2022, focuses on early-stage investments in supply chain, agriculture, restaurant innovation, automation, and other areas aligned with Chipotle's mission. The additional funding will expand the portfolio, which includes investments in Local Line, GreenField Robotics, Nitricity, Vebu, Hyphen, Meati Foods, and Zero Acre Farms. These investments aim to support Chipotle's growth plans and mission to Cultivate a Better World.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:26 pm

MRT

Marti, identified by its ticker symbol MRT, has officially launched a taxi-hailing service, expanding its offerings in the transportation sector. This move is expected to diversify Marti's revenue streams and enhance its competitive position in the market.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:19 pm

CMPX

Compass Therapeutics announced the publication of preclinical data for CTX-8371 in OncoImmunology, marking progress towards its first-in-human clinical trial. This development could signal a significant step forward in the company's pipeline and potentially impact its valuation positively if the clinical trials are successful.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:13 pm

QUIK

QuickLogic Corporation has signed a significant seven-figure contract to provide its embedded FPGA (eFPGA) Intellectual Property (IP) for GlobalFoundries' 12LP process. This deal underscores QuickLogic's expertise and the demand for its eFPGA solutions, potentially boosting its financial performance and market position.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:12 pm

NATL

NCR Atleos Corporation (NYSE:NATL), a leader in financial access expansion, announced its partnership with VyStar Credit Union to provide its members with surcharge-free access to cash through the Allpoint ATM Network. This collaboration aims to support VyStar's growth by offering access to over 40,000 ATMs nationwide and more than 10,000 international locations, enhancing the credit union's service offerings to its expanding member base.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:11 pm

SPRO

Spero Therapeutics has received clearance for its Investigational New Drug (IND) application for SPR206, aimed at treating multi-drug resistant (MDR) Gram-negative bacterial infections. This development marks a significant step forward in the company's efforts to address a critical need in the healthcare sector for new antibiotics capable of combating resistant bacteria.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:08 pm

GEHC

GE HealthCare (NASDAQ:GEHC) launched its new LOGIQ ultrasound portfolio, including LOGIQ Totus, at the European Congress of Radiology 2024. The portfolio features advanced AI tools and the LOGIQ AppAPI for third-party applications, aiming to address the global shortage of radiologists and improve clinical efficiency. The LOGIQ E10 Series and LOGIQ Fortis offer AI-based workflow tools, while the LOGIQ Totus provides a versatile solution for full-body imaging. PIUR IMAGING's 'PIUR tUS inside' is integrated for thyroid examination.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 1:07 pm